SNRPB rs6138178: What Your Genotype Means
The rs6138178 variant is a single nucleotide polymorphism located within the SNRPB gene. Research has identified this variant as a potential genetic modifier associated with breast cancer risk in individuals who carry BRCA1 or BRCA2 mutations.
What each genotype means
Typical breast cancer risk
This genotype represents the more common form of this variant. Research indicates that carriers of the alternative allele may have a reduced risk of breast cancer if they also carry a BRCA1 mutation, meaning this genotype does not confer that specific protective association.
This is the major genotype found in most global populations.
Potential risk modifier
This genotype includes one copy of the rare allele. In studies of BRCA1 mutation carriers, this allele has been associated with a statistically significant reduction in breast cancer risk.
The rare allele is observed at lower frequencies across most studied populations.
Potential risk modifier
This genotype includes two copies of the rare allele. Research suggests this variant may act as a modifier of breast cancer risk specifically for individuals who carry a BRCA1 mutation.
This genotype is rare in the general population.
Understanding the Variant and Its Location
The rs6138178 variant is a specific change in the DNA sequence located within the SNRPB gene. In genetics, a single nucleotide polymorphism (SNP) represents a variation at a single position in the DNA chain. This particular SNP is situated in a region of the genome that has been studied for its influence on complex traits. Because it is located within a gene, researchers investigate whether this variation alters the gene's function or the way it is expressed in different tissues. Geneticists use large-scale studies, such as genome-wide association studies (GWAS), to identify these markers and determine if they correlate with specific health outcomes or physical traits across diverse populations.
The Role of the SNRPB Gene
The SNRPB gene provides instructions for making a protein that is a core component of the spliceosome. The spliceosome is a complex molecular machine within the cell that performs pre-mRNA splicing, a critical process that removes non-coding segments of RNA called introns and joins together the coding segments called exons. By regulating this process, SNRPB helps ensure that the correct proteins are produced from genetic information. Dysregulation of this splicing mechanism can lead to the production of unexpected mRNA variants, which may influence cellular behavior. Because of its fundamental role in gene expression, researchers have explored how variations in SNRPB might contribute to tumorigenesis and other cellular processes in various types of human cancer.
Research Associations and Evidence Strength
Scientific research has investigated rs6138178 as a modifier of breast cancer risk, particularly in individuals who already carry pathogenic mutations in the BRCA1 or BRCA2 genes. Studies, such as those published in Human Molecular Genetics, have observed that the minor allele of rs6138178 is associated with a reduced risk of breast cancer in BRCA1 mutation carriers. It is important to note that the evidence for this association is considered moderate. While these findings provide valuable insights into how genetic background can influence the penetrance of BRCA mutations, these associations do not reach the level of absolute clinical prediction. The influence of such variants is often subtle, and they are typically studied as part of a broader polygenic risk profile rather than as standalone diagnostic markers.
Interpreting Genetic Information
It is essential to understand that genetic associations are statistical observations made across large groups of people and cannot predict an individual's health outcome with certainty. Having a specific genotype for rs6138178 does not mean an individual will or will not develop a condition. This information is intended for educational purposes to help the public understand the complexity of genetic risk modifiers. Individuals concerned about their personal risk for breast cancer, especially those with a family history or known BRCA mutations, should consult with a genetic counselor or a healthcare professional. These experts can provide personalized risk assessments based on comprehensive clinical data, family history, and established medical guidelines, rather than relying on single genetic variants.
How common is this variant?
The rs6138178 variant is considered rare in the general population. Its frequency can vary significantly depending on ancestral background.
Frequently asked questions
What is the SNRPB gene?
The SNRPB gene encodes a protein that is a vital part of the spliceosome, which is responsible for processing pre-mRNA in cells. It plays a key role in ensuring that genetic instructions are correctly assembled.
Does rs6138178 cause breast cancer?
No, rs6138178 is not a cause of breast cancer. It is a genetic variant that has been statistically associated with modifying the level of risk in individuals who already carry BRCA1 or BRCA2 mutations.
Should I get tested for this SNP?
Genetic testing for specific SNPs like rs6138178 is generally not performed in a clinical setting for routine risk assessment. You should discuss any concerns about cancer risk with a doctor or genetic counselor.
Where can I find more information on BRCA mutations?
MedlinePlus Genetics provides comprehensive, reliable information about BRCA1 and BRCA2 genes and their role in hereditary cancer risk. You can visit their website to learn more about genetic testing and counseling.
Sources & further reading
Educational information only, last refreshed 11/4/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs6138178?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29